Rigor Reviewed

Rigor-Reviewed Manuscript

Navigational Bronchoscopy or Transthoracic Needle Biopsy for Lung Nodules.

Name: Αlpha¹ Rigor Record — Navigational Bronchoscopy or Transthoracic Needle Biopsy for Lung Nodules.
Item: Navigational Bronchoscopy or Transthoracic Needle Biopsy for Lung Nodules.
Rating: 59
Author: Αlpha¹

Lentz RJ, Frederick-Dyer K, Planz VB, Koyama T, Aboudara MC, Avasarala SK, Casey JD, Cheng GZ, D'Haese PF, Duke JD, Grogan EL, Hoopman TC, Johnson J, Katsis JM, Kurman JS, Low SW, Mahmood K, Rickman OB, Roller L, Salmon C, Shojaee S, Swanner B, Wahidi MM, Walston C, Silvestri GA, Yarmus L, Rahman NM, Maldonado F, Interventional Pulmonary Outcomes Group

Paper source

Read full text (PMC)

Embed this Rigor badge

Αlpha¹ Rigor Review — 3★ (Adequate), 0 critical, 3 high issues for “Navigational Bronchoscopy or Transthoracic Needle Biopsy for Lung Nodules.”

Links back to this Rigor Record.

Αlpha¹ Editorial

This rigor review was examined and confirmed by Αlpha¹ Editorial · August 15, 2026

Αlpha¹ Rigor Review

Rigor Reviewed

3 / 5

Adequate — real issues to address

Interventional Study

Critical

High-priority

How this rating was calculated▸

Started at 5★ — deductions

IntegrityIntegrity concern−0.5★
ClaimsOverstated claim−0.5★
CitationsUnresolved reference ×2−0.5★
StatisticsPrinted percentage does not match its own count (capped) ×3−0.25★
ReportingData & code availability partially met−0.25★

Model-reported confidence: highReviewer agreement: highEngine: 7.39.0Source: full text

Not verified in this report

No data or code availability links were detected to verify.

Problems surfaced5 types

Numerical inconsistencies2

Values that contradict each other or are impossible for the stated sample: recomputed p-values and test statistics, GRIM/GRIMMER checks on summary numbers, percentages against their own counts, totals against their parts, and estimates against their own confidence intervals.

Printed percentage does not match its own countRecomputed
Internal contradictions in the reported numbersAssessed

Overstated conclusions1

Conclusions that reach past what the paper's own results support — including a significance claim that no longer holds when the statistic is recomputed, and efficacy resting on an unvalidated surrogate endpoint.

Conclusions overstated beyond the evidenceAssessed

Reporting gaps1

Required detail the manuscript never states — study design, biological variables, ethics approval and consent, key resources, statistical reporting, data and code availability, and overall transparency.

Data/code availability incompleteAssessed

Broken references and links1

References checked against Crossref, OpenAlex and Retraction Watch for retractions and resolvability, plus declared data and code links probed for whether they resolve to content matching the paper.

References not resolvable to a published paperRecomputed

This Αlpha¹ Rigor Review uses AI Rigor Reviewers trained on a curated corpus of high-fidelity and retracted papers, with expert supervision and curation. It can still make mistakes; verify each finding against the source before relying on it.

This is a well-designed and well-reported randomized noninferiority trial with clear scientific premise, rigorous methods, and transparent reporting. The main weaknesses are the lack of a data availability statement and minor inconsistencies in reported safety percentages.

Both reviewers agreed on study type (interventional) and all dimension statuses. The statistics verification component recomputed only a subset of tests (5 total, 3 inconsistent) and cannot confirm overall statistical correctness; the copyedit flagged a discrepancy in pneumothorax percentages between the abstract and Table 3.

5 major claims checked against the paper's own evidence: 1 not fully backed by the presented evidence (unsupported or overstated).

Efficacy claim is anchored to an adequate endpoint and a meaningful effect.

Recomputed 1 test: 1 consistent, 0 inconsistent; 1 via agent-written checks. 3 printed percentages that do not match their own count.

1 integrity concern flagged (0 high).

Reporting

Eight Dimensions7 pass · 1 warn

The introduction cites prior studies and meta-analyses on both biopsy modalities, acknowledges their limitations (single-arm studies, selection bias), and states the hypothesis. The rationale for the noninferiority design is clear.

Sub-criteria

prior work citedADEQUATE

premise rationaleADEQUATE

limitations addressedADEQUATE

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 90% conf

The paper establishes a clear scientific premise with prior work cited and a logical rationale for the trial.

Evidence

direct quote[Introduction, paragraph 1]

“Diagnostic accuracy estimates for both modalities have been derived from single-arm studies at high risk for selection, referral, and publication biases.”